Vertex Pharmaceuticals Inc (VRTX)
450.38
-0.85
(-0.19%)
USD |
NASDAQ |
Nov 21, 16:00
450.38
0.00 (0.00%)
After-Hours: 17:50
Vertex Pharmaceuticals Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.2594 |
| September 30, 2016 | 0.2915 |
| June 30, 2016 | 0.3021 |
| March 31, 2016 | 0.3091 |
| December 31, 2015 | 0.314 |
| September 30, 2015 | 0.3197 |
| June 30, 2015 | 0.3294 |
| March 31, 2015 | 0.3019 |
| December 31, 2014 | 0.2742 |
| September 30, 2014 | 0.255 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.5361 |
| December 31, 2012 | 0.4003 |
| September 30, 2012 | 0.3892 |
| June 30, 2012 | 0.3854 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
--
Maximum
Dec 2019
--
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Gilead Sciences Inc | 1.258 |
| Eli Lilly and Co | 2.185 |
| Bristol-Myers Squibb Co | 2.902 |
| Moderna Inc | 0.00 |
| Pfizer Inc | 0.7219 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 22.24B |
| Total Liabilities (Quarterly) | 6.609B |
| Shareholders Equity (Quarterly) | 15.63B |
| Current Ratio | 2.468 |